Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern? Published on 2023-04-062024-09-05 Journal: Molecular Therapy. Nucleic Acids [키워드] MPro Nirmatrelvir Omicron subvariant SARS-CoV-2 significant mutation [저자] Srijan Chatterjee, Manojit Bhattacharya, Kuldeep Dhama, Sang-Soo Lee, Chiranjib Chakraborty [Category] update2024, PMC URL Pubmed URL DOI URL [DOI] 10.1016/j.omtn.2023.03.013 [Article Type] Editorial [Source] PMC All Keywords 【저자키워드】 SARS-CoV-2, MPro, Nirmatrelvir, Omicron subvariant, significant mutation,